This document summarizes the role of clinical pharmacists and information technology in enhancing patient safety in medication use at Hoan My Sai Gon Hospital. It discusses how clinical pharmacists monitor medication administration, adverse drug reactions, and therapeutic drug monitoring. It also explains how the hospital utilizes an information technology system to reduce medication errors by checking for drug interactions, maximum doses, and dispensing errors. The results shown indicate increases in clinical pharmacist involvement and a 100% reduction in contraindicated drug interactions after implementing the IT system.
Current Trends in Pharmacy Practice and Overview of (1).pptShakirAliyi
The document discusses current challenges in pharmacy practice in Ethiopia, including knowledge and skill gaps among professionals. It proposes strategies to improve practice through implementing patient-focused training, in-service clinical pharmacy training, and advancing clinical pharmacy services. Clinical pharmacy aims to shift the focus from drug products to patient care by applying pharmaceutical expertise to maximize drug efficacy and safety.
Medication Safety- Administration and monitoring.pptxLatha Venkatesan
The document discusses medication safety and reducing medication errors. It covers several key points:
1) Medication errors are common, especially during transitions of care between settings. The WHO aims to reduce medication-related harm by 50% through their "Medication Without Harm" challenge.
2) Medication errors can occur at various stages like prescribing, transcribing, dispensing, and administering. High-risk medications and situations like polypharmacy also increase error risk.
3) Strategies to improve safety include training, protocols, technology like CPOE, reconciliation, and empowering patients. A multidisciplinary team approach is important to strengthen systems and practices.
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdflaonedikgang1
This document provides an overview of managing medication use processes to reduce errors. It discusses the five stages of the medication use process: prescribing, transcribing, distribution, administration, and monitoring. For each stage, potential errors are described. Centralized and decentralized drug distribution models are compared. National patient safety goals and strategies for researching and preventing errors like failure mode and effects analysis and root cause analysis are also covered. The presentation aims to describe medication use processes and discuss ways to improve safety.
The document summarizes updates from the Pharmacy and Therapeutics Committee, including approval of new non-formulary and formulary drugs. Fingolimod and teriflunomide were approved as non-formulary drugs for treating multiple sclerosis. Anidulafungin was approved as a formulary antifungal drug. The document also provides information on pharmacy services, guidelines, new medications added to the formulary, and efforts to minimize medication errors.
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
The document discusses guidelines for nurse prescribers working in emergency departments in the UK. It outlines their roles in obtaining patient history, assessing conditions, making treatment plans, prescribing medications, and ensuring patient safety. Nurse prescribers must follow ethical codes to provide compassionate and competent care, maintain patient privacy, and consider the patient's best interests.
The document describes Prescription Event Monitoring (PEM), a method of pharmacovigilance that involves collecting information on patient outcomes after being prescribed new medications. PEM was developed in the 1980s in the UK to address limitations of spontaneous adverse event reporting. It involves sending questionnaires to prescribers to obtain follow-up data on patients. Analysis of the data provides incidence rates of adverse events and allows detection of potential safety issues with new drugs. Modified PEM (M-PEM) expands the method to collect additional targeted safety information.
This document summarizes a presentation on promoting rational use of medicines. It discusses:
1) The definition of rational drug use and the magnitude of irrational use globally. Interventions like standard treatment guidelines and educational strategies are discussed.
2) Data on inadequate diagnosis and overuse of injections in developing countries is presented.
3) Strategies to promote rational use include educational, managerial, economic and regulatory approaches. Educational strategies target both providers and consumers. Managerial strategies include essential drug lists and supervision. Economic strategies aim to remove financial incentives for irrational prescribing.
4) Studies evaluating the impact of various interventions like training, supervision, guidelines and public policies generally find a significant positive effect on rational drug use outcomes. Multi-
Current Trends in Pharmacy Practice and Overview of (1).pptShakirAliyi
The document discusses current challenges in pharmacy practice in Ethiopia, including knowledge and skill gaps among professionals. It proposes strategies to improve practice through implementing patient-focused training, in-service clinical pharmacy training, and advancing clinical pharmacy services. Clinical pharmacy aims to shift the focus from drug products to patient care by applying pharmaceutical expertise to maximize drug efficacy and safety.
Medication Safety- Administration and monitoring.pptxLatha Venkatesan
The document discusses medication safety and reducing medication errors. It covers several key points:
1) Medication errors are common, especially during transitions of care between settings. The WHO aims to reduce medication-related harm by 50% through their "Medication Without Harm" challenge.
2) Medication errors can occur at various stages like prescribing, transcribing, dispensing, and administering. High-risk medications and situations like polypharmacy also increase error risk.
3) Strategies to improve safety include training, protocols, technology like CPOE, reconciliation, and empowering patients. A multidisciplinary team approach is important to strengthen systems and practices.
Lecture 5_Managing People & Pharmacy Operations (PART II to III) (1).pdflaonedikgang1
This document provides an overview of managing medication use processes to reduce errors. It discusses the five stages of the medication use process: prescribing, transcribing, distribution, administration, and monitoring. For each stage, potential errors are described. Centralized and decentralized drug distribution models are compared. National patient safety goals and strategies for researching and preventing errors like failure mode and effects analysis and root cause analysis are also covered. The presentation aims to describe medication use processes and discuss ways to improve safety.
The document summarizes updates from the Pharmacy and Therapeutics Committee, including approval of new non-formulary and formulary drugs. Fingolimod and teriflunomide were approved as non-formulary drugs for treating multiple sclerosis. Anidulafungin was approved as a formulary antifungal drug. The document also provides information on pharmacy services, guidelines, new medications added to the formulary, and efforts to minimize medication errors.
Dr.sherin elsherbiny
Senior registrar clinical microbiology
AMR coordinator
Infection control auditor
Riyadh region
Meeqat General Hospital ,Madina,KSA
The document discusses guidelines for nurse prescribers working in emergency departments in the UK. It outlines their roles in obtaining patient history, assessing conditions, making treatment plans, prescribing medications, and ensuring patient safety. Nurse prescribers must follow ethical codes to provide compassionate and competent care, maintain patient privacy, and consider the patient's best interests.
The document describes Prescription Event Monitoring (PEM), a method of pharmacovigilance that involves collecting information on patient outcomes after being prescribed new medications. PEM was developed in the 1980s in the UK to address limitations of spontaneous adverse event reporting. It involves sending questionnaires to prescribers to obtain follow-up data on patients. Analysis of the data provides incidence rates of adverse events and allows detection of potential safety issues with new drugs. Modified PEM (M-PEM) expands the method to collect additional targeted safety information.
This document summarizes a presentation on promoting rational use of medicines. It discusses:
1) The definition of rational drug use and the magnitude of irrational use globally. Interventions like standard treatment guidelines and educational strategies are discussed.
2) Data on inadequate diagnosis and overuse of injections in developing countries is presented.
3) Strategies to promote rational use include educational, managerial, economic and regulatory approaches. Educational strategies target both providers and consumers. Managerial strategies include essential drug lists and supervision. Economic strategies aim to remove financial incentives for irrational prescribing.
4) Studies evaluating the impact of various interventions like training, supervision, guidelines and public policies generally find a significant positive effect on rational drug use outcomes. Multi-
COMMON ERRORS IN DISPENSING by Mrs omorodion 3.pptxAnijuKenechukwu
a presentation on the common dispensing error encountered in a pharmacy and the role of pharmacy technicians in curbing or reducing the rate of these common errors
The document discusses current trends in clinical pharmacy practice. It describes how clinical pharmacy focuses on optimizing medication therapy to promote health and prevent disease. It outlines several clinical pharmacy services including ward rounds, therapeutic drug monitoring, medication therapy management, and drug information services. The document also discusses the processes of pharmaceutical care and medication therapy management, which involve pharmacists collaborating with other providers and patients to design and monitor therapeutic plans to improve patient outcomes. It emphasizes the importance of these services in ensuring safe and cost-effective pharmacotherapy.
This document discusses pharmacovigilance challenges related to biotherapeutic medicines. It notes that biotherapeutics differ from chemically synthesized molecules in their complexity and sensitivity, posing challenges like immunogenicity and exaggerated pharmacology. Different regulatory pathways for biotherapeutics also require comprehensive pharmacovigilance planning. Effective pharmacovigilance requires identifying biotherapeutics, thorough record keeping and reporting, and ongoing safety monitoring due to factors like interchangeability of products and the potential for different safety profiles. The International Nonproprietary Name system also presents challenges for distinguishing biotherapeutics.
ADVERSE DRUG REACTION | PHARMACY PRACTICE | PDF | SHIVAM DUBEY B PHARMA | PHA...MrHotmaster1
PHARMACY PRACTICE
SHIVAM DUBEY
BPYN1PY18041
ADVERSE DRUG REACTION Abstract
We define an adverse drug reaction as "an appreciably harmful or
unpleasant reaction
An Essential Drug List, also known as a core drug list or medication list, is a carefully selected inventory of medications that are deemed essential for addressing the most prevalent health conditions within a specific population or country. It serves as a key component of national drug policies and pharmaceutical programs, ensuring the availability, accessibility, and affordability of essential medicines. The list is typically developed based on rigorous criteria, taking into consideration the medications' safety, efficacy, cost-effectiveness, and suitability for primary healthcare settings.
Rational Drug Therapy refers to the systematic and evidence-based approach to prescribing medications, aiming to maximize therapeutic benefits while minimizing the risk of adverse effects. It involves following established therapeutic guidelines and clinical protocols to ensure that medications are prescribed in a manner that is appropriate for the patient's condition, taking into account factors such as age, weight, co-existing conditions, drug interactions, and individual response. Rational drug therapy promotes the use of medications based on sound scientific evidence, emphasizing the principles of efficacy, safety, and cost-effectiveness to optimize patient outcomes and improve overall healthcare quality.
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...Until ROI
The document discusses the growth of pharmacovigilance in India. It notes that while pharmacovigilance is still in its infancy in India, major advancements have been made in Western countries. It outlines the benefits of developing pharmacovigilance in India, including its large population and growing economy. Challenges to pharmacovigilance in India include its predominantly rural population, extensive use of traditional medicines, and lack of awareness among physicians and consumers. The document calls for building a more robust pharmacovigilance system in India through mandatory reporting, inspections, training programs, and collaborations.
This study evaluated the utilization pattern of antibiotics at a tertiary care teaching hospital in North Karnataka, India by analyzing 250 patient prescriptions. The most commonly prescribed antibiotic classes were cephalosporins and fluoroquinolones. Comparison to clinical guidelines found deviations in diagnostic testing and treatment. For many conditions like pneumonia and bronchitis, sputum testing was not performed before antibiotic prescription. Overall antibiotic use could be more rational by adhering closer to treatment guidelines. Pharmacist involvement in drug use evaluation programs may help improve antibiotic use and patient outcomes.
Prescription event monitoring and record linkage systemRumana Hameed
PEM is a method of pharmacovigilance that studies drug safety in real-world clinical practice. It involves collecting prescription data for new drugs and surveying prescribers about patient outcomes. Advantages include a large national scale and obtaining real-world safety data. Record linkage systems combine different healthcare records to efficiently study relationships between drug exposure and health outcomes. Claims databases contain prescription and medical claims information but may lack clinical details, while medical record databases provide more clinical data but only for illnesses that were medically attended to.
I am professionally pharmacist. These slides for clinical subject especially for pharmacy department students. I hope students get more benefits about it.
The document summarizes the presentation given by Ms. Eloisa E. Ramos on patient safety goals at Procare Riaya Hospital. It discusses the 6 International Patient Safety Goals including identifying patients correctly, improving communication, safety of high-alert medications, ensuring correct-site surgery, reducing healthcare-associated infections, and reducing falls. Key points from each goal are provided such as using two patient identifiers, implementing processes for verbal orders and reporting critical test results, and assessing and mitigating patient fall risks. The document aims to improve safety and quality of care through understanding and implementing the Joint Commission International's patient safety standards.
This document discusses medication adherence and proposes a mHealth approach using automated medication reminders triggered from pharmacy dispensing data to improve adherence. Key points:
- Medication non-adherence is a major healthcare problem, with 50% of chronic patients not following treatment plans. This costs $100-290 billion annually in the US.
- An automated reminder system would use dispensing data like medication name, dose, frequency from pharmacies to set reminders in an app to prompt users when to take medications and track adherence.
- This approach could improve medication adherence rates especially as more use smartphones and wearables, helping address the large costs and health impacts of non-adherence.
Here are some examples of contributing factors and categories involved/detected:
Contributing factors:
- Look-alike, sound-alike drug names
- Distraction during medication preparation
- Poor communication of prescription
Categories involved:
- Pharmacist, nurse
Category detected:
- Patient, pharmacist
User Guide III : Create Medication Error Report
Part B: Location and Error Outcome
1. Location of Facility
Select the exact location where the error occurred.
2. Department/ Ward
Select the department/ ward where the error occurred.
3. Error Outcome
Select the outcome of the error.
Part C: Patient's Particulars
1. Patient
The document provides information about hospital formularies, including their definition, purpose, contents, and preparation. It defines a hospital formulary as a list of pharmaceutical preparations selected by the medical staff that reflects current clinical views. The key benefits of a formulary system are therapeutic, economic, and educational. A formulary aims to provide information on approved drug products, hospital policies, and special sections. It undergoes regular review and revision by the Pharmacy and Therapeutics Committee to ensure only cost-effective products are used.
Goal 1 improve the accuracy of patient identification.npsssuser47f0be
The document discusses patient identification and reducing errors related to misidentification. It focuses on using two patient identifiers, which can help reliably identify individuals and match them to the correct service or treatment. Newborns are at higher risk given their inability to communicate and lack of distinguishing features. The document provides examples of methods to prevent misidentification of newborns such as distinct naming systems and standardized identification banding practices.
Ομιλία – Παρουσίαση: Raymond Anderson, President Commonwealth Pharmaceutical Association and Member of the Pharmacovigilance Risk Assessment Committee (PRAC) at EMA
«Best Practices to inform citizens on Self-medication»
this is research study conducted in tertiary hospital namely kidney center in KP pakistan to assess the level of knowledge of professional Nurses regarding administrator of parental medication to patient suffering with kidney diseases to ensure and help in safe parental medication to patients in hosptals.
The document describes a study conducted by Dr. Nguyen Nhu Ho on a non-pharmacological approach for treating insomnia in elderly patients. It provides background on insomnia and current treatment methods. The study involved pharmacist-led behavioral interventions using Brief Behavioral Treatment for Insomnia techniques over 4 weeks. Outcomes were measured before and after using the PSQI and EQ-5D-5L scales. A guidebook was also developed to educate patients and healthcare professionals on the BBTI procedures. The goal was to determine if the pharmacist-led BBTI intervention could improve sleep quality and life quality for elderly patients with chronic insomnia.
Markov Modeled Cost - effectiveness analysis of ICS/Formoterol versus Fluticasone/Salmeterol in the Outpatients treatment of Bronchial Asthma at Binh Thanh District Hospital
More Related Content
Similar to Enhancing Patient Safety-HMSG-Thu Ba-Eng-V1.pdf
COMMON ERRORS IN DISPENSING by Mrs omorodion 3.pptxAnijuKenechukwu
a presentation on the common dispensing error encountered in a pharmacy and the role of pharmacy technicians in curbing or reducing the rate of these common errors
The document discusses current trends in clinical pharmacy practice. It describes how clinical pharmacy focuses on optimizing medication therapy to promote health and prevent disease. It outlines several clinical pharmacy services including ward rounds, therapeutic drug monitoring, medication therapy management, and drug information services. The document also discusses the processes of pharmaceutical care and medication therapy management, which involve pharmacists collaborating with other providers and patients to design and monitor therapeutic plans to improve patient outcomes. It emphasizes the importance of these services in ensuring safe and cost-effective pharmacotherapy.
This document discusses pharmacovigilance challenges related to biotherapeutic medicines. It notes that biotherapeutics differ from chemically synthesized molecules in their complexity and sensitivity, posing challenges like immunogenicity and exaggerated pharmacology. Different regulatory pathways for biotherapeutics also require comprehensive pharmacovigilance planning. Effective pharmacovigilance requires identifying biotherapeutics, thorough record keeping and reporting, and ongoing safety monitoring due to factors like interchangeability of products and the potential for different safety profiles. The International Nonproprietary Name system also presents challenges for distinguishing biotherapeutics.
ADVERSE DRUG REACTION | PHARMACY PRACTICE | PDF | SHIVAM DUBEY B PHARMA | PHA...MrHotmaster1
PHARMACY PRACTICE
SHIVAM DUBEY
BPYN1PY18041
ADVERSE DRUG REACTION Abstract
We define an adverse drug reaction as "an appreciably harmful or
unpleasant reaction
An Essential Drug List, also known as a core drug list or medication list, is a carefully selected inventory of medications that are deemed essential for addressing the most prevalent health conditions within a specific population or country. It serves as a key component of national drug policies and pharmaceutical programs, ensuring the availability, accessibility, and affordability of essential medicines. The list is typically developed based on rigorous criteria, taking into consideration the medications' safety, efficacy, cost-effectiveness, and suitability for primary healthcare settings.
Rational Drug Therapy refers to the systematic and evidence-based approach to prescribing medications, aiming to maximize therapeutic benefits while minimizing the risk of adverse effects. It involves following established therapeutic guidelines and clinical protocols to ensure that medications are prescribed in a manner that is appropriate for the patient's condition, taking into account factors such as age, weight, co-existing conditions, drug interactions, and individual response. Rational drug therapy promotes the use of medications based on sound scientific evidence, emphasizing the principles of efficacy, safety, and cost-effectiveness to optimize patient outcomes and improve overall healthcare quality.
GROWTH OF PHARMACOVIGILANCE IN INDIA Dr Deven V Parmar MD Vice President – Gl...Until ROI
The document discusses the growth of pharmacovigilance in India. It notes that while pharmacovigilance is still in its infancy in India, major advancements have been made in Western countries. It outlines the benefits of developing pharmacovigilance in India, including its large population and growing economy. Challenges to pharmacovigilance in India include its predominantly rural population, extensive use of traditional medicines, and lack of awareness among physicians and consumers. The document calls for building a more robust pharmacovigilance system in India through mandatory reporting, inspections, training programs, and collaborations.
This study evaluated the utilization pattern of antibiotics at a tertiary care teaching hospital in North Karnataka, India by analyzing 250 patient prescriptions. The most commonly prescribed antibiotic classes were cephalosporins and fluoroquinolones. Comparison to clinical guidelines found deviations in diagnostic testing and treatment. For many conditions like pneumonia and bronchitis, sputum testing was not performed before antibiotic prescription. Overall antibiotic use could be more rational by adhering closer to treatment guidelines. Pharmacist involvement in drug use evaluation programs may help improve antibiotic use and patient outcomes.
Prescription event monitoring and record linkage systemRumana Hameed
PEM is a method of pharmacovigilance that studies drug safety in real-world clinical practice. It involves collecting prescription data for new drugs and surveying prescribers about patient outcomes. Advantages include a large national scale and obtaining real-world safety data. Record linkage systems combine different healthcare records to efficiently study relationships between drug exposure and health outcomes. Claims databases contain prescription and medical claims information but may lack clinical details, while medical record databases provide more clinical data but only for illnesses that were medically attended to.
I am professionally pharmacist. These slides for clinical subject especially for pharmacy department students. I hope students get more benefits about it.
The document summarizes the presentation given by Ms. Eloisa E. Ramos on patient safety goals at Procare Riaya Hospital. It discusses the 6 International Patient Safety Goals including identifying patients correctly, improving communication, safety of high-alert medications, ensuring correct-site surgery, reducing healthcare-associated infections, and reducing falls. Key points from each goal are provided such as using two patient identifiers, implementing processes for verbal orders and reporting critical test results, and assessing and mitigating patient fall risks. The document aims to improve safety and quality of care through understanding and implementing the Joint Commission International's patient safety standards.
This document discusses medication adherence and proposes a mHealth approach using automated medication reminders triggered from pharmacy dispensing data to improve adherence. Key points:
- Medication non-adherence is a major healthcare problem, with 50% of chronic patients not following treatment plans. This costs $100-290 billion annually in the US.
- An automated reminder system would use dispensing data like medication name, dose, frequency from pharmacies to set reminders in an app to prompt users when to take medications and track adherence.
- This approach could improve medication adherence rates especially as more use smartphones and wearables, helping address the large costs and health impacts of non-adherence.
Here are some examples of contributing factors and categories involved/detected:
Contributing factors:
- Look-alike, sound-alike drug names
- Distraction during medication preparation
- Poor communication of prescription
Categories involved:
- Pharmacist, nurse
Category detected:
- Patient, pharmacist
User Guide III : Create Medication Error Report
Part B: Location and Error Outcome
1. Location of Facility
Select the exact location where the error occurred.
2. Department/ Ward
Select the department/ ward where the error occurred.
3. Error Outcome
Select the outcome of the error.
Part C: Patient's Particulars
1. Patient
The document provides information about hospital formularies, including their definition, purpose, contents, and preparation. It defines a hospital formulary as a list of pharmaceutical preparations selected by the medical staff that reflects current clinical views. The key benefits of a formulary system are therapeutic, economic, and educational. A formulary aims to provide information on approved drug products, hospital policies, and special sections. It undergoes regular review and revision by the Pharmacy and Therapeutics Committee to ensure only cost-effective products are used.
Goal 1 improve the accuracy of patient identification.npsssuser47f0be
The document discusses patient identification and reducing errors related to misidentification. It focuses on using two patient identifiers, which can help reliably identify individuals and match them to the correct service or treatment. Newborns are at higher risk given their inability to communicate and lack of distinguishing features. The document provides examples of methods to prevent misidentification of newborns such as distinct naming systems and standardized identification banding practices.
Ομιλία – Παρουσίαση: Raymond Anderson, President Commonwealth Pharmaceutical Association and Member of the Pharmacovigilance Risk Assessment Committee (PRAC) at EMA
«Best Practices to inform citizens on Self-medication»
this is research study conducted in tertiary hospital namely kidney center in KP pakistan to assess the level of knowledge of professional Nurses regarding administrator of parental medication to patient suffering with kidney diseases to ensure and help in safe parental medication to patients in hosptals.
Similar to Enhancing Patient Safety-HMSG-Thu Ba-Eng-V1.pdf (20)
The document describes a study conducted by Dr. Nguyen Nhu Ho on a non-pharmacological approach for treating insomnia in elderly patients. It provides background on insomnia and current treatment methods. The study involved pharmacist-led behavioral interventions using Brief Behavioral Treatment for Insomnia techniques over 4 weeks. Outcomes were measured before and after using the PSQI and EQ-5D-5L scales. A guidebook was also developed to educate patients and healthcare professionals on the BBTI procedures. The goal was to determine if the pharmacist-led BBTI intervention could improve sleep quality and life quality for elderly patients with chronic insomnia.
Markov Modeled Cost - effectiveness analysis of ICS/Formoterol versus Fluticasone/Salmeterol in the Outpatients treatment of Bronchial Asthma at Binh Thanh District Hospital
Chloroquine has been shown to be effective against SARS-CoV-2 in vitro and has a well-established safety profile due to decades of use for malaria prevention and treatment. It is a cheap and widely available drug. Chinese researchers plan to promptly evaluate chloroquine's potential use for both preventing and treating the disease caused by the novel coronavirus, based on these promising in vitro results. If clinical trials confirm the biological effects, chloroquine could become one of the simplest and most affordable treatments available for this respiratory infection.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Know the difference between Endodontics and Orthodontics.Gokuldas Hospital
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfRahul Sen
Time-lapse embryo monitoring is an advanced imaging technique used in IVF to continuously observe embryo development. It captures high-resolution images at regular intervals, allowing embryologists to select the most viable embryos for transfer based on detailed growth patterns. This technology enhances embryo selection, potentially increasing pregnancy success rates.
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
1. "Enhancing safety for patients
in using medication at Hoan My Sai Gon Hospital:
The role of clinical pharmacists and information technology
Nguyen Thi Thu Ba, Pharm., Msc.
Head of Pharmacy Department –HMSG Hospital
Quy Nhon, 9/2023
2. 15-17 August 2023
Speaker’s introduction
Nguyen Thi Thu Ba, Pharm., MSc.
Summary of the training process:
1979-1984: Graduated as a Pharmacist. Ho Chi Minh City University of Medicine and
Pharmacy
1993-1994: Graduated from Level 1 Specialization, majoring in Hospital Pharmacy and
Pharmacy Management at Hanoi Pharmacy University
1999-2001: Specialization in Clinical Pharmacy, Master in Biomedical Sciences at Rangueil
University, Toulouse III, France.
Work experiences:
1984-1999: 15 years of teaching at the Department of Pharmacy, Central Medical School No.2
Ministry of Health, now Danang University of Medical Technology and Pharmacy
1999-2000: Resident Pharmacist in Clinical Pharmacy at the Pharmacy Department of
Montauban Hospital, France.
11/2001 - 2/2021: 19 years: Head of Pharmacy Department of Hoan My Da Nang Hospital,
concurrently 10 years as Pharmaceutical Manager of Hoan My Medical Group.
3/2021 to present: Head of Pharmacy Department of Hoan My Saigon Hospital
Scientific research and quality improvement topics:
23 scientific research projects and 8 quality improving projects have been reported, including
1 report at the ACCP 2013
1 report at the APSIC (Asia-Pacific infectious disease conference) 2019
1 project received the Excellence Award from the Asia Hospital Management Association in the
Philippines in 2017
3. Outline
1
2
3
4
5
Medication errors- a major patient risk
The role of clinical pharmacists in promoting
patient safety in medication use
Applying information technology to
improve patient safety
Results
Conclusion
4. World Patient Safety Day 17.12.2022. WHO office on Quality of Care and Patient Safety (Athens, Greece)
1. Bloodborne Pathogens
2. Catheter-Associated Uninary Tract
Infection (CAUTI)
3. Diagnostic Errors
4. Hacked Medical Devices
5. Healthcarre-Associated Venous
Thromboembolism
6. Hospital-Acquired Pneumonia
7. Medication Errors
8. Methicillin-resistant Staphylococcus
aureus (MRSA)
9. Post-discharge Adverse Events
10. Sepsis
Top 10 patient safety risks in hospitals
WHO-2022
in Europe:
The Rate of ME ranges from
0.3% to 9.1% in prescription
In USA: 25%
In HMSG Hospital: < 0.5%
5. Take a look at some of medication errors that cause serious harm to patients, even
death…
In Vietnam
In March 2018, a district medical
center of Tien Giang Province
mistakenly prescribed
Misoproston (abortion pills) to
three pregnant women instead of
Miprotone (an embryo-nourishing
pills).
In foreign countries
50-year-old women, accidental
administration of epinephrine
instead of midazolam during
colonoscopyinprep
Gado A, Accidental IV administration of epinephrine instead of
midazolam at colonoscopy. Alexandria J of Med. 2016;62(1)
In 2016, 5 adult patients
unintentionally received insulin
(Humalog U-100) instead of the
influenza vaccine at a public
school clinic in Missouri
Drugs Ther Perspect. 2016. 32: 439-
doi:10.1007/s40267-016-0333-2
In July 2023, an 85-year-old
woman with a 20-year history of
hypertension was admitted to
the National Hospital of
Endocrine after accidentally
taking a hypoglycemic medicine.
Hypoglycemia, seizure, drowsy,
consciousness disorders
6. 2. The urgent need to reduce medication errors in hospitals to prevent patient and second victim harm [White paper]. European Collaborative Action On Medication Errors
and Traceability (ECAMET); 2022 (https://eaasm.eu/wp-content/uploads/ECAMET-White-Paper-Call-to-Action-March-2022-v2.pdf, accessed 5 August 2022)
Medication
Errors
(ME)
most common
ME in dispensing:
wrong patient,
wrong drug,
wrong dosage form
1.6% to 2.1% (2)
ME in prescribing:
wrong dose,
wrong quantity,
drug interaction
0.3% to 9.1% (2)
ME in administration:
Wrong patient,
Wrong drug,
Wrong dose,
Wrong route,
Wrong time
8%-25% (1)
1. Patient Safety Network, 2018
7. Hoan My Sai Gon Hospital:
❖ OPD: 1700 – 2000 prescriptions/day
❖ IPD: 400 medication orders/day
Big problems:
HOW WE CAN
• Avoid and prevent harm to patients
• Protect reputation and brand of hospital
• Protect medical staff from legal errors
rate of ME:
0,1% - 0,37%
8.
9. The role of clinical pharmacists in enhancing
patient safety in medication use at HMSGH
OUTPATIEN
T
INPATIENT
DOSE
DRUG
INTERACTIONS
CONTRAINDICATION
The most
common
medication
errors
Dose adjustments
and drugs utilization
in specific groups
2022-2023: Our GOALS
1. Check: 100% medication orders and prescriptions
2. Control to keep the rate of ME: less than 0.5% of total prescriptions.
3. Prevent: 100% ME from prescribing, dispensing, administrating from
reaching to patients
10. The role of clinical pharmacist in monitoring and intervention medication administration
Pharmacists in clinical departments:
- diagnostic meeting
- monitoring the efficacy and safety of
medication treatments in specific groups of
patients: renal/liver failures
- evaluating, choosing alternative drugs for
patients with ADR.
Dose adjustment
ADR
Specific groups
serious illness patients
with polypharmacy
11. The role of clinical pharmacist in monitoring medication use
Vancomycin Therapeutic Drug Monitoring
🡪 Giving advices on dose adjustments
Monitoring and evaluation ADR
🡪 Finding patient’s medical history or
previous drugs hypersensitivity reactions
12. How can we achieve our SMART GOALS with just only 3 clinical pharmacists?
Check and alert
duplicated drugs in
prescriptions
Check and alert
contraindicated
drug interactions
Check and alert
daily maximum
dose or maximum
quantity for a
period of a
prescription
Check and prevent
errors in dose unit
and delivery unit
Signs to identify high
risk and fall-risk
medication
Suppling patient
info on label of
each medicine
Training and Performing professional
pharmacy staff to be able to:
- Validate prescriptions, MO
- Diagnosic and give
recommendations to select
medicines
- TDM, ADR, monitoring medication
use in clinical services
Our Strategy = Active Roles of Pharmacists + Information Technology
14. ▪ Importing ADR reports easily.
▪ Distributing informations to responsible staffs and
hospital administrators.
▪ Sending ADR reports to National DI & ADR Centre.
Applying information technology to improve patient safety
16. E-learning program will be used to train new health
workers, including doctors, nurses, and pharmacists.
Applying information technology to improve patient safety
17. This document is strictly private and confidential
17
17
In daily clinical practice, we have applied IT in
alerting and blocking overlapped
prescriptions of same active ingredients
❑ Database already in operation
❑ Constantly updating the
medication list
❑ IT alert and block
overlapped prescriptions of
same active ingredients
18. This document is strictly private and confidential
18
18
Setting up an alert and blocking system to prevent the prescription of
contraindicated drug combinations according to MOH regulation.
❑ 131 contraindicated drug-drug
interactions
❑ 1/2022: Set up the alert system
❑ 28/2/2023: Officially operated
❑ Clinical pharmacists supply Database ❑ IT: alert & blocking system
19. This document is strictly private and confidential
19
19
2. The display of the contraindicated drug interactions alert in one or >two prescriptions
20. This document is strictly private and confidential
20
20
3. Installing maximum doses for the system to alert and preventing
doctors prescribing over maximum doses
❑ 358 brand names and
generics in total
❑ Including maximum single
dose, daily dose, dose
frequency, and dose
duration
❑ Operated since 28/02/2023
21. This document is strictly private and confidential
21
21
3. The display of maximum dose alert and blocking system
❑ Alert and blocking system
for maximum doses:
- single dose,
- daily dose,
- dose frequency,
- dose of a therapy duration
❑ Effectively operated since
28/02/2023
22. This document is strictly private and confidential
22
22
4. Setting up database for preventing errors in dose unit and dispensing unit of
multidose drug products in electronic medical records/prescriptions
Default unit of dose on HIS
The prescriber can alter appropriately
Name Ingredient
Dispensing
unit
Dose
Unit
Mixtard 30 Flexpen
100 UI/ mL, 3 mL
Combined Insulin
rapid/retard 30/70
Pen IU
Mixtard 30 HM 100 UI/
mL, 10 mL
Combined Insulin
rapid/retard 30/70
Vial IU
NovoMix 30 Flexpen
100 UI/ mL, 3 mL
Combined Insulin
rapid/retard 30/70
Pen IU
Ryzodex Flextouch
100 UI/ mL, 3 mL
Insulin aspart
+Insulin degludec
Pen IU
Ganfort (0,3 mg + 5
mg)/ mL, 3 mL
Bimatoprost +
Timolol
Vial
Drop
Dermovate Cream
0,05%, 15g
Clobetazol
Probionate
Tube Time
Symbicort
Turbuhaler 160 mcg
+ 4,5mcg (60 dose)
Budenoside +
Formoterol
Symbicort
Turbuhaler 160 mcg
+ 4,5mcg (60 dose)
Budenos
ide + Formoterol
Vial Pump
23. Tất cả thông tin trong tài liệu này được bảo mật
5. Solutions to reduce ME in dispensing medication
1. Preparing and dispensing drugs: developing the medication
double-checking processes
2. Hospital Information System (HIS): Allowing to show drug
information such as: drug name, strength, manufacturers, lot,
expired date on drugs dispensing notes
24. 5.1. Developing the medication double-checking processes
Guideline for
implementation and
management of
high risk medication
25. This document is strictly private and confidential
25
25
Inpatient
5.2. Showing drug information such as: drug name, strength, labeller – country on goods
transfer note
Outpatient
26. 178
thuốc
57 ca 7 khoa
LS
6. Monitoring nurses administrating medicines on patients
“6 rights” of medication use:
1. The right patient:
2. The right drug
3. The right dose
4. The right route of administration
5. The right time
6. The right document
Auditing the 6 right of medication use
27. 7. Help to identify and manage utilization high risk and falling
risk medications
Pharmacists:
Update the database of
formulary
HIS
1
2
IT system help to
Bold names of high-risk medications
Italicize name of falling risk medications
28. This document is strictly private and confidential
28
28
Solutions to prevent wrong route:
❑Drugs which have one route of administration
❖ IV infusion→ “IV infusion”
❖ Subcutaneous injection → “Subcutaneous injection”
❖ Intramuscular injection→ “Intramuscular injection”
❖ IV bolus→ “IV bolus”
❖ Intradermal injection→ “Intradermal injection”
❑ Various routes of administration: IV, IM,
SC, ID → “Injection”
❑ Various routes of administration : IV, IM,
SC, ID, IV Infusion → “parenteral route ”
❑ Concentrated solution: Adding “Dilute
before injecting”
29. Tất cả thông tin trong tài liệu này được bảo mật
To reduce ME in administrating drugs on
patients
The high-risk medications are bolded in
medication chart notes
31. Tất cả thông tin trong tài liệu này được bảo mật
Increasing number of cases of diagnostic meetings, ADR reports, AB monitoring on patients by pharmacists
138 cases
82
90
113
121
106 111
0
20
40
60
80
100
120
140
Tháng
1
Tháng
2
Tháng
3
Tháng
4
Tháng
5
Tháng
6
Số ca KSƯTQLSD đã giám sát 6 tháng đầu năm 2023
3 9 13 16 20 13
4.1%
12.2%
17.6%
21.6%
27.0%
17.6%
0.0%
5.0%
10.0%
15.0%
20.0%
25.0%
30.0%
0
5
10
15
20
25
T 1 T 2 T 3 T 4 T 5 T 6
The number of ADR reports in the first half of 2023
Số lượng Tỷ lệ
%
74 cases
52
27
33 32
27
35
0
10
20
30
40
50
60
Tháng 1 Tháng 2 Tháng 3 Tháng 4 Tháng 5 Tháng 6
Số ca Hội chẩn theo từng tháng
15 14 12 7 17 11 13 8 16 9 6 10
11%
10%
9%
5%
12%
8%
9%
6%
12%
7%
4%
7%
0%
2%
4%
6%
8%
10%
12%
14%
0
2
4
6
8
10
12
14
16
18
Tháng 01 Tháng 02 Tháng 03 Tháng 04 Tháng 05 Tháng 06 Tháng 07 Tháng 08 Tháng 09 Tháng 10 Tháng 11 Tháng 12
The number of ADR reports monthly in 2022
Số lượng Tỷ lệ
Quantity %
Quantity
32. Tất cả thông tin trong tài liệu này được bảo mật
Increasing the number of cases of TDM of vancomycin and dose adjustment
7
3
7
2
4
8
0
2
4
6
8
10
Tháng
1
Tháng
2
Tháng
3
Tháng
4
Tháng
5
Tháng
6
The number of Vancomycin TDM
cases in the first half of 2023
1
3
5
1 1 1
2
1 1
0
2
4
6
01-22
02-22
03-22
04-22
05-22
06-22
07-22
08-22
09-22
10-22
11-22
12-22
The number of Vancomycin TDM cases
between 04 – 06/2022
16 cases
31 cases
33. Tất cả thông tin trong tài liệu này được bảo mật
34. Tất cả thông tin trong tài liệu này được bảo mật
Up to 100% reduction in contraindicated drug interactions
1 1 11 3 3 2 2 1 2
0.004%
0.003%
0.036%
0.009%
0.009%
0.006%
0.006%
0.003%
0.007%
0.000%
0.010%
0.020%
0.030%
0.040%
0
2
4
6
8
10
12
ME cases Percentage (%)
Before After
6/2022 7/2022 8/2022 9/2022 10/2022 11/2022 12/2022 01-07/2023
Percentages
of reduction
of ME
73% 73% 82% 82% 91% 100% 82% 100%
35. Tất cả thông tin trong tài liệu này được bảo mật
Dropping importantly the amount of refusing insurance payout
due to medication errors in prescribing
36. Tất cả thông tin trong tài liệu này được bảo mật
Conclusion
Pharmacists
play an
important
role in
enhancing
patient safety
Information
technology is
quite essential
to support and
improve
patient safety
Doctors and
nurses have
always
played key
roles in
reducing ME
Continue to
find strategies
to prevent ME
and promote
patient safety